The same differentiation method was used for CAH patient-specific cells (urine derived MCS or iPSCs from peripheral lymphocytes, that was firstly directed to mesodermal lineage) with different mutations in the CYP21A2, CYP17A1 and CYP11B1 genes. The gene discussed is CYP21A2; the disease is congenital adrenal hyperplasia.